LPCAT1 overexpression promotes the progression of hepatocellular carcinoma.

Rong-Quan HeJian-Di LiXiu-Fang DuYi-Wu DangLin-Jie YangZhi-Guang HuangLi-Min LiuLiu-Feng LiaoHong YangGang Chen

Published in: Cancer cell international (2021)

The present study demonstrated that increased LPCAT1 correlated with poor prognosis in HCC patients and fuelled HCC progression by promoting cellular growth, migration, and metastasis.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
cell proliferation
transcription factor
patient reported outcomes